Overview

Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
SP746 (NCT00546351) is a multi-center, open-label, follow-on trial. The purpose of this trial is to assess safety and tolerability of long-term exposure of lacosamide (previously referred to as SPM 927) in subjects with painful distal diabetic neuropathy.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Pharma
Treatments:
Lacosamide